InsidersTradesSigma
Total declarations
Companies
▲ Purchases (11 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
11
Disclosed sells
0
T+90 hit rate
17%
T+90 mean return
-38.1%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Patience John, Director. Director active across 2 companies, notably BIODESIX INC. Aggregated, 20 filings have been published. Split: 11 buys · 0 sell. Total volume traded: €3.5m. Activity tracked since 17 August 2021. The latest transaction was filed on 3 December 2024 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Patience John
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
1,361 sharesCommon StockSEC:0000905148-26-003146:0
1,361 sharesCommon StockSEC:0000905148-26-001495:0
1,143 sharesCommon StockSEC:0000905148-26-000072:0
1,144 sharesCommon StockSEC:0000905148-25-003485:0
22,874 sharesCommon StockSEC:0000905148-25-002317:0
46,686 sharesCommon StockSEC:0000905148-25-001047:0
200,000 shares@ US$1.5750.9% of flowCommon StockSEC:0001104659-24-125217:0
Canonical exit: 3 Mar 2025 (T+90)
75,000 shares@ US$1.38282.4% of flowCommon StockSEC:0000905148-24-002948:0
Canonical exit: 3 Feb 2025 (T+90)
217,400 sharesCommon StockSEC:0000905148-24-001605:0
16,666 sharesCommon StockSEC:0001104659-24-006670:0
Canonical exit: 22 Apr 2024 (T+90)
61,728 shares@ US$1.622.3% of flowCommon StockSEC:0000905148-23-000626:0
1,739,130 shares@ US$1.1548.5% of flowCommon StockSEC:0001140361-22-042602:0
Canonical exit: 19 Feb 2023 (T+90)
279,329 shares@ US$1.7914.0% of flowCommon StockSEC:0001567619-22-008354:0
Canonical exit: 6 Jul 2022 (T+90)
137,931 shares@ US$4.3516.1% of flowCommon StockSEC:0001567619-22-000275:0
Canonical exit: 30 Mar 2022 (T+90)
21,702 shares@ US$7.6832.5% of flowCommon StockSEC:0001628280-21-024838:0
10,000 shares@ US$6.17531.7% of flowCommon StockSEC:0001567619-21-021148:0
Canonical exit: 21 Feb 2022 (T+90)
9,497 shares@ US$6.34091.6% of flowCommon StockSEC:0001567619-21-020954:0
Canonical exit: 16 Feb 2022 (T+90)
8,396 shares@ US$8.03831.8% of flowCommon StockSEC:0001567619-21-016211:0
Canonical exit: 17 Nov 2021 (T+90)
1,604 shares@ US$7.11740.3% of flowCommon StockSEC:0000905148-21-000612:0
Canonical exit: 15 Nov 2021 (T+90)
50,000 sharesCommon StockSEC:0001144204-16-080134:0
Canonical exit: 9 May 2016 (T+90)
20 of 20 declarations
About Patience John
Patience John is Administrateur of BIODESIX INC and Accelerate Diagnostics, Inc. Across 20 filings in total, the 20 sampled filings cover the period from 2016-02-09 to 2026-07-02, with EUR 3494357 of purchases and EUR 0 of sales, and the most frequent transaction nature is Acquisition.
